Phase II study of KX2-391 ointment 1%, a novel field treatment for actinic keratosis, based on Src/tubulin polymerization inhibitionMichael Jarratt,Steven Kempers,Seth Forman,David Cutler,Hui Wang,Jane Fang,Rudolf KwanJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY（2018）引用 2|浏览15暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
